WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke ANNA BIOSCIENCES wurde als Wortmarke am 06.04.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1660856 |
| Länder | 
|
| Basismarke |
Nr. 90621293,
02. April 2021
|
| Anmeldedatum | 06. April 2021 |
| Ablaufdatum | 06. April 2031 |
Markeninhaber
12 Merrion Square
Dublin 2
IE
Dublin 2
IE
Markenvertreter
1000 TOWN CENTER, 22ND FLOOR
SOUTHFIELD MI 48075
US
Waren und Dienstleistungen
05
Biological, medicinal and pharmaceutical preparations,
namely, therapeutics for the treatment of infertility,
genetic, viral, metabolic, endocrine, musculoskeletal,
cardiovascular, cardiopulmonary, neuromuscular, rare muscle
diseases, cardiomyopathies, heart muscle diseases, muscular
dystrophies, muscle atrophy, genitourinary, sexual
dysfunction, oncological, hepatological, ophthalmic,
respiratory, neurological, gastrointestinal, hormonal,
dermatological, psychiatric and immune system related
diseases and disorders; diagnostic preparations for medical
and clinical laboratory use; dietetic preparations, namely,
nutritional supplements based on vitamins, minerals and
probiotics; chemicals for use in medical laboratories,
namely, diagnostic chemicals
41
Computer services, namely, providing educational information
about chemicals, pharmaceuticals, diagnostic and laboratory
products as well as biochemical, biological, chemical,
immunochemical and immunological compositions and
preparations provided through a website and distributed via
global computer network
42
Product development for others relating to pharmaceuticals,
biopharmaceuticals, health care products and medical
products; scientific and technological consulting services
in the pharmaceutical industry, and research and design
relating thereto; industrial analysis in the nature of
product testing and research and industrial research in the
field of pharmaceuticals, biopharmaceuticals, health care
products and medical products; pharmaceutical and
biopharmaceutical drug development services; pharmaceutical
and biopharmaceutical research and development; product
development consultation; product research services, namely,
providing analytical testing, biosafety testing, reporting
and laboratory services for others; scientific and technical
product development consulting and research services for the
pharmaceutical industry; custom design and development of
chemical reagents and biochemical assays; research and
development services in the field of cancer immunotherapy;
conducting clinical trials for others in the field of cancer
immunotherapy; scientific and industrial research; planning
and executing projects in the area of the supply of
pharmaceuticals, namely, development of pharmaceutical
substances, providing know-how, information and consulting
services in high throughput screening of chemicals during
chemical analysis, chemical synthesis, toxicological and
pharmaceutical research, genome target identification and
validation, consulting services in production and
development in the field of pharmaceuticals,
biopharmaceuticals, health care products and medical
products, animal and human pharmacokinetic evaluations,
consulting services by providing clinical development
concepts; providing on-line computer databases featuring
medical terminology, medical and pharmaceutical data and
scientific, medical and pharmaceutical counseling
information (term considered too vague by the International
Bureau - Rule 13 (2) (b) of the Regulations); drawing up
scientific expert reports, documents and information;
planning, performing and evaluating scientific studies;
counseling with regard to ensuring drug safety and services,
namely, providing respective information to patients,
doctors and clients (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Regulations);
services rendered in the laboratory and chemical area,
namely, development of analytical methods and drug master
files, reviewing standards and practices to assure
compliance with pharmaceutical application and regulation
requirements and consultation in the area of upscaling of
laboratory processes (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Regulations);
services relating to pharmaceutical preparations, namely,
medical research, namely, providing information in printed
form and via electronic means in the fields of oncology,
metabolic and cardiovascular diseases or disorders, and
diseases and disorders of the central nervous system (term
considered too vague by the International Bureau - Rule 13
(2) (b) of the Regulations)
44
Providing information and counseling in healthcare; drawing
up medical and pharmaceutical expert reports, documents and
information; consulting services rendered in the medical,
pharmaceutical, and pharma-economy sector; services relating
to pharmaceutical preparations, namely, healthcare and
medical advice, disease management, patient support
services, namely, providing information in printed form and
via electronic means in the fields of oncology, metabolic
and cardiovascular diseases or disorders, and diseases and
disorders of the central nervous system
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 23. Februar 2023 | 2023/8 Gaz | JP | Ablehnung |
| 26. Oktober 2022 | 2022/43 Gaz | CN | Ablehnung |
| 29. September 2022 | 2022/39 Gaz | EM | Ablehnung |
| 11. August 2022 | 2022/32 Gaz | GB | Ablehnung |
| 06. Juni 2022 | 2022/23 Gaz | IN | Ablehnung |
| 17. Mai 2022 | 2022/21 Gaz | AU | Ablehnung |
| 06. April 2021 | 2022/17 Gaz | US | Eintragung |
ID: 141660856